NEUROCRINE BIOSCIENCES INC 4
4 · NEUROCRINE BIOSCIENCES INC · Filed May 5, 2017
Insider Transaction Report
Form 4
LYLE CORINNE H
Director
Transactions
- Exercise/Conversion
Common Stock
2017-05-03$3.40/sh+15,000$51,000→ 40,555 total - Tax Payment
Common Stock
2017-05-03$53.37/sh−952$50,808→ 39,603 total - Exercise/Conversion
Non-Qualified Stock Option
2017-05-03−15,000→ 0 totalExercise: $3.40From: 2010-06-25Exp: 2017-05-25→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]The share issuance reported on Table I reflects shares issued upon the exercise of options granted on May 25, 2010, which, if unexercised would have expired on May 25, 2017. The option exercises are reported on Table II. These option exercises were pursuant to a net issuance arrangement effected under the issuer's Equity Incentive Plan. The number of shares issued pursuant to the net issuance arrangement was calculated as follows: the option exercise price ($3.40) was subtracted from the May 03, 2017 market close price ($53.57), and this net amount ($50.17) was then multiplied by the number of options (15,000), with the resulting amount then divided by the market close price to result in a net issuance of 14,048 shares to the optionee. The 952 shares underlying the remaining portion of the options are not available for re-issuance, and no shares were sold into the market as a part of the exercise in connection with a net issuance program.